Reports

14158 Results (Page 261 of 567)

All Market Research Reports

Pharmaceuticals

Mexico Antibacterial (Antibiotics) Drugs Market Analysis

Mexico Antibacterial (Antibiotics) Drugs Market is at around $0.76 Bn in 2023 and is projected to reach $1.04 Bn in 2030, exhibiting a CAGR of 4.45% during the forecast period. The industry is expanding due to factors like medical tourism, increased resistance to antibiotics, and awareness and education. The market is dominated by key players like AbbVie (Allergan), Pfizer, AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., Novartis AG, Eli Lilly, and Bayer.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

India Dermatological Therapeutics Market Analysis

India Dermatological Therapeutics Market is at around $0.77 Bn in 2022 and is projected to reach $1.65 Bn in 2030, exhibiting a CAGR of 11.6% during the forecast period. The market is expanding due to factors like improved healthcare infrastructure, increased awareness and demand, and technological advancements. The market is dominated by key players like Gladerma India Private Limited (IND), Dr. Reddy’s Laboratories (IND), Cipla (IND), Sun Pharmaceutical Industries (IND), Lupin (IND), Zydus Cadila (IND), Torrent Pharmaceuticals (IND), Alkem Laboratories (IND), Glenmark Pharmaceuticals (IND), Pfizer, Johnson & Johnson, Novartis AG, and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Antibacterial (Antibiotics) Drugs Market Analysis

Brazil Antibacterial (Antibiotics) Drugs Market is at around $21.38 Bn in 2023 and is projected to reach $24.9 Bn in 2030, exhibiting a CAGR of 2.2% during the forecast period. The market is expanding due to factors such as population growth, rising healthcare costs, and an increase in the incidence of infectious diseases. The market is dominated by key players like EMS Pharmaceutica S.A., Abbott Laboratories, Pfizer, AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., Novartis AG, and Roche Holding AG.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Antibacterial (Antibiotics) Drugs Market Analysis

Saudi Arabia Antibacterial (Antibiotics) Drugs Market is at around $0.86 Bn in 2023 and is projected to reach $1.2 Bn in 2030, exhibiting a CAGR of 5.7% during the forecast period. The market is being driven by rising healthcare expenditures, rapid urbanization, and an increase in the prevalence of infectious diseases. The market is dominated by key players like Hikma Pharmaceuticals, Tabuk Pharmaceuticals, AbbVie, Pfizer, GlaxoSmithKline (GSK), Johnson & Johnson Inc. (J&J), Merck & Co., Sanofi, Novartis, and F. Hoffmann-La Roche Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Antibacterial (Antibiotics) Drugs Market Analysis

US Antibacterial (Antibiotics) Drugs Market is at around $21.38 Bn in 2023 and is projected to reach $24.9 Bn in 2030, exhibiting a CAGR of 2.2% during the forecast period. Several factors, including the prevalence of infectious diseases, the development of antibiotic resistance, and technological advancements are driving growth in the market. The market is dominated by key players like Pfizer Inc., GlaxoSmithKline (GSK), Johnson & Johnson (J&J), Merck & Co., Inc., Abbott Laboratories, Astra Zeneca, Sanofi, F. Hoffmann-La Roche Ltd, Bayer AG, Bristol-Myers Squibb Company, Novartis AG, and Astellas Pharma Inc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Antibacterial (Antibiotics) Drugs Market Analysis

Canada Antibacterial (Antibiotics) Drugs Market is at around $4.07 Bn in 2023 and is projected to reach $5.4 Bn in 2030, exhibiting a CAGR of 4.2% during the forecast period. The market is being driven by factors such as the rise in infectious disease incidence, the expansion of healthcare infrastructure, and the increase in awareness and education. The market is dominated by key players like Pfizer Canada, GlaxoSmithKline (GSK), Johnson & Johnson Inc. (J&J), Merck Canada, Abbott Laboratories Limited, Astra Zeneca Canada, Sanofi Canada, Novartis Pharmaceuticals Canada Inc., Eli Lilly Canada Inc., and F. Hoffmann-La Roche Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Dermatology Drugs Market Analysis

By 2030, it is anticipated that the Vietnam Dermatology drugs market will reach a value of $xx Mn from $85 Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as Traphaco, Pymepharco, and Imexpharm. The market is driven by the prevalence of dermatology conditions, awareness about dermatological health, and increasing healthcare spending. The dermatology drug market in Vietnam is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Medical Devices

Vietnam Coronary Stents Market Analysis

Vietnam Coronary Stents Market is expected to witness growth from $57 Mn in 2022 to $83 Mn in 2030 with a CAGR of 4.98% for the forecasted year 2022-30. A growing number of foreign patients seeking reasonably priced medical treatments, such as coronary stenting, are choosing Vietnam as their destination of choice for medical tourism. The market for coronary stents is anticipated to rise as a result of more medical institutions increasing their product offerings to meet the needs of this market. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Vinamed, VietMedical, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Acne Therapeutics Market Analysis

This report presents a strategic analysis of the Vietnam Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Acne Therapeutics Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis

This report presents a strategic analysis of the Vietnam ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Digital Health

US Digital Therapeutics Market Analysis

US Digital Therapeutics Market is at around $2.6 Bn in 2023 and is projected to reach $12.6 Bn in 2030, exhibiting a CAGR of 27.2% during the forecast period. The market is being driven by factors such as the rise in chronic diseases, technological advancements, and the adoption of telehealth. The market is dominated by key players like DarioHealth Corp., Banner Health, Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Cardiovascular Drugs Market Analysis

US Cardiovascular Drug Market is at around $58.1 Bn in 2022 and is projected to reach $67.01 Bn in 2030, exhibiting a CAGR of 1.8% during the forecast period. The major reasons propelling the growth of this market are the increasing prevalence of chronic diseases, technological advancements, and the rise in government initiatives, among others. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., Astra Zeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Cardiovascular Drugs Market Analysis

Spain Cardiovascular Drug Market is at around $2.67 Bn in 2022 and is projected to reach $3.30 Bn in 2030, exhibiting a CAGR of 2.8% during the forecast period. Major reasons propelling the growth of this market are the increasing prevalence of chronic diseases and technological advancements. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Cardiovascular Drugs Market Analysis

Malaysia Cardiovascular Drug Market is at around $0.22 Bn in 2022 and is projected to reach $0.30 Bn in 2030, exhibiting a CAGR of 4% during the forecast period. The market is driven by factors such as the aging population, increasing incidence of cardiovascular diseases, and enhanced screening and diagnostics. The market is dominated by key players like Pharmaniaga Berhad, Duopharma Biotech Bhd, B Braun Medical Industries (M) Sdn Bhd, Eschol Pharmaceuticals Sdn Bhd, CCM Pharmaceuticals (SGP), Pfizer Inc., Astra Zeneca, Sanofi, Zydus, and Lupin.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Cardiovascular Drugs Market Analysis

Singapore Cardiovascular Drug Market is at around $0.17 Bn in 2022 and is projected to reach $0.23 Bn in 2030, exhibiting a CAGR of 4.4% during the forecast period. Aging population, rising prevalence of cardiovascular diseases, and increasing healthcare spending are all driving the market. The market is dominated by key players like iNova Pharmaceuticals (SGP), Eshcol Pharmaceutical Group (SGP), Wellchem Pharmaceuticals (SGP), Adjuvanz Technology (SGP), CCM Pharmaceuticals (SGP), Zydus, Pfizer Inc., Lupin, GSK, and Glenmark Pharmaceuticals.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Cardiovascular Drugs Market Analysis

Brazil Cardiovascular Drug Market is at around $3.5 Bn in 2022 and is projected to reach $5.03 Bn in 2030, exhibiting a CAGR of 4.8% during the forecast period. Primary factors driving the expansion of this industry include government initiatives, increasing prevalence of cardiovascular diseases, and an aging population. The market is dominated by key players like Eurofarma, Nortec Química (BRA), Drogaria do Povo (BR), Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, and Merck & Co., Inc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Digital Health

Vietnam 3D Imaging Market Analysis

Vietnam's 3D imaging market is projected to grow from $0.15 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by the growing need for modern medical technology, greater emphasis on enhancing healthcare services, and rising investments in cutting-edge medical technology. The market is segmented by product, application, end-user & portability. Some of the major players include GE Healthcare, Siemens Healthineers & FPT Corporation

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Venezuela Retail Pharmacy Market Analysis

This report presents a strategic analysis of the Venezuela Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Venezuela Retail Pharmacy Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Healthcare Services

Venezuela Patient Support Programs (PSP) Market Analysis

This report presents a strategic analysis of the Venezuela Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Venezuela Patient Support Programs (PSP) Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Healthcare Services

Venezuela Palliative Care Market Analysis

Venezuela's Palliative care market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be the increasing prevalence of chronic diseases, the aging population, and technological advances. The market is segmented by service type and by the end user. Some of the major players include Hospice Vida Plena, Hospice Foundation Venezuela, Cuidados paliativos, and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Medical Devices

Venezuela Medical Devices Market Analysis

This report presents a strategic analysis of the Venezuela Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Venezuela Medical Devices Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Healthcare Services

Venezuela In Vitro Fertilisation (IVF) Service Market Analysis

This report presents a strategic analysis of the Venezuela In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about Venezuela's In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Digital Health

Venezuela Digital Health Market Analysis

Venezuela's Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be viable only in the presence of a stable political and economic climate, as well as greater investment in digital health technology and infrastructure. The market is segmented by solution, by deployment & by end-use. Some of the major players include IBM, Cisco Systems & few other private companies active in the digital health market in Venezuela.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Venezuela Breast Cancer Therapeutics Market Analysis

Venezuela's breast cancer therapeutics market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the year 2022-30 due to the rising incidence of breast cancer cases in Venezuela. The market is segmented by therapy, by cancer type, and by distribution channel. Fundafarmacia, Celgene, and Halozyme are some of the major companies in Venezuela's breast cancer therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Venezuela ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis

This report presents a strategic analysis of the Venezuela ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Venezuela ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up